Indian Biotechnology: An "Earn while you Learn" Model

The absence of Venture Capital in the early days and the onset of risk-averse venture funding at the present time has compelled Indian Biotech start-ups to pursue a revenue earning business strategy from their inception. Consequently, many companies have adopted a services model much along the lines of the IT sector. Others have pursued a product based business model where vaccines and biogenerics have dominated. A few companies have been set up as Indian arms of US and European Biotech companies. Unfortunately, whilst there are parallels being drawn between IT and Biotech, in reality, there are distinct differences which are illustrated in the following chart -

Public Acceptance